AssetMark Inc’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$72.1K Buy
12,788
+4,444
+53% +$33.5K ﹤0.01% 1754
2026
Q2
$86.9K Buy
8,344
+1,392
+20% +$15.5K ﹤0.01% 1667
2026
Q1
$82.7K Buy
6,952
+2,460
+55% +$25.2K ﹤0.01% 1604
2025
Q4
$44.7K Sell
4,492
-942
-17% -$9K ﹤0.01% 1757
2025
Q3
$48.6K Sell
5,434
-95
-2% -$880 ﹤0.01% 1644
2025
Q2
$52.1K Buy
5,529
+2,581
+88% +$22.8K ﹤0.01% 1551
2025
Q1
$32K Buy
2,948
+47
+2% +$473 ﹤0.01% 1569
2024
Q4
$27.6K Buy
+2,901
New +$29.4K ﹤0.01% 1579

Other funds holding AHCO

AssetMark Inc's AHCO Position: Q3 2026 in Review

AssetMark Inc increased its AdaptHealth (AHCO) stake by 53% in Q3 2026, buying an estimated $33.5K and bringing the position to 12,788 shares worth $72.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1754.

AssetMark Inc first reported a position in AHCO in Q4 2024 and has held it in 8 quarters since. The position peaked at $86.9K in Q2 2026. 93 funds tracked by Wall St. Rank hold AHCO as of Q3 2026.

  • AssetMark Inc held 12,788 shares of AdaptHealth worth $72.1K as of Q3 2026.
  • AssetMark Inc bought 4,444 AdaptHealth shares in Q3 2026, an estimated $33.5K.
  • AdaptHealth made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #1754 holding.
  • AssetMark Inc first reported a position in AdaptHealth in Q4 2024 and has held it in 8 quarters since.
  • AssetMark Inc's AdaptHealth position peaked at $86.9K in Q2 2026.
  • 93 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.